Cefepime Hydrochloride Injection, Powder, For Solution
Product Images NDC 0143-9477
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cefepime Hydrochloride (NDC 0143-9477). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Vial Label (Cefepime For Injection Novaplus 2)
Carton Label (Cefepime For Injection Novaplus 3)
This text provides information about a medication called Cefepime for Injection, USP, in the form of 1 gram per vial. It includes instructions to reconstitute before intramuscular use and dilute before intravenous infusion. The medication is contained in 10 x 1 gram single-dose vials, and each vial contains sterile Cefepime Hydrochloride USP equivalent to 1 gram of Cefepime. The usual dosage information is available in the package insert. It also gives storage instructions, requiring storage in a dry state at 20°C to 25°C and protection from light. The medication is manufactured by Hikma Farmaceutica (Portugal), SA and distributed by Hikma Pharmaceuticals USA Inc.*
Vial Label (Cefepime For Injection Novaplus 4)
This text provides information on Cefepime for injection, USP, with 2 grams per vial. It is intended for single-dose use for intravenous infusion. The instructions indicate exclusive use with a certain type of syringes and specify the recommended storage conditions. The lot and expiration date are also included.*
Carton Label (Cefepime For Injection Novaplus 5)
Description: This text is a label for Cefepime for Injection, a medication that comes in the form of 10 single-dose vials containing 2 grams each. It provides instructions on dilution before intravenous infusion and storage conditions. It also mentions the manufacturer, distributor, and a registered trademark. Dosage information is advised to be obtained from the package insert.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.